28.02.24
Fondazione Telethon announces commitment to make gene therapy for Wiskott-Aldrich syndrome available to patients
On the eve of the 26th World Rare Disease Day, Fondazione Telethon announces its commitment to ensure that gene therapy for Wiskott-Aldrich syndrome (WAS), a rare genetic disease of the immune system, will be available in the next future.
From Telethon Foundation
12.09.23
Fondazione Telethon and Orchard Therapeutics complete transfer of marketing authorization of Strimvelis for ADA-SCID in Europe
Una nuova sfida per Telethon, che amplia i confini della propria missione
From Telethon Foundation
20.04.23
Fondazione Cariplo and Fondazione Telethon: 21 projects funded with 5 million euros for basic research in rare diseases
The best projects of the 2022 call for basic research from all over Italy to study still obscure portions of our genetic heritage have been funded. The collaboration between Fondazione Cariplo and Fondazione Telethon continues: 21 new basic research projects have been funded for a total of about 5 million euros. The goal of the […]
From Telethon Foundation